3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(3H-pyrazol-5-ylmethyl)indazole

C85H73N23O — CID 160645179

IUPAC3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(3H-pyrazol-5-ylmethyl)indazole
SMILESC1=C(Cn2nc(-c3ccccc3)c3ccccc32)N=NC1.Cc1cc(Cn2nc(-c3ccccc3)c3ccccc32)on1.Cn1cc(Cn2nc(-c3ccccc3)c3ccccc32)nn1.Cn1ncnc1Cn1nc(-c2ccccc2)c2ccccc21.Cn1nnc(Cn2nc(-c3ccccc3)c3ccccc32)n1
InChIInChI=1S/C18H15N3O.2C17H15N5.C17H14N4.C16H14N6/c1-13-11-15(22-20-13)12-21-17-10-6-5-9-16(17)18(19-21)14-7-3-2-4-8-14;1-21-11-14(18-20-21)12-22-16-10-6-5-9-15(16)17(19-22)13-7-3-2-4-8-13;1-21-16(18-12-19-21)11-22-15-10-6-5-9-14(15)17(20-22)13-7-3-2-4-8-13;1-2-6-13(7-3-1)17-15-8-4-5-9-16(15)21(20-17)12-14-10-11-18-19-14;1-21-18-15(17-20-21)11-22-14-10-6-5-9-13(14)16(19-22)12-7-3-2-4-8-12/h2*2-11H,12H2,1H3;2-10,12H,11H2,1H3;1-10H,11-12H2;2-10H,11H2,1H3
InChIKeyRJRQBKOJPPXFNC-UHFFFAOYSA-N
MW1432.68 g/mol
LogP16.14
Rot. Bonds15

About 3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(3H-pyrazol-5-ylmethyl)indazole

3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(3H-pyrazol-5-ylmethyl)indazole (PubChem CID 160645179) has the molecular formula C85H73N23O and a molecular weight of 1432.68 g/mol. Its IUPAC name is 3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(3H-pyrazol-5-ylmethyl)indazole.

Molecular Properties

Compound Name3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(3H-pyrazol-5-ylmethyl)indazole
PubChem CID160645179
Molecular FormulaC85H73N23O
Molecular Weight1432.68 g/mol
Exact Mass1431.64
IUPAC Name3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(3H-pyrazol-5-ylmethyl)indazole
SMILESC1=C(Cn2nc(-c3ccccc3)c3ccccc32)N=NC1.Cc1cc(Cn2nc(-c3ccccc3)c3ccccc32)on1.Cn1cc(Cn2nc(-c3ccccc3)c3ccccc32)nn1.Cn1ncnc1Cn1nc(-c2ccccc2)c2ccccc21.Cn1nnc(Cn2nc(-c3ccccc3)c3ccccc32)n1
InChIInChI=1S/C18H15N3O.2C17H15N5.C17H14N4.C16H14N6/c1-13-11-15(22-20-13)12-21-17-10-6-5-9-16(17)18(19-21)14-7-3-2-4-8-14;1-21-11-14(18-20-21)12-22-16-10-6-5-9-15(16)17(19-22)13-7-3-2-4-8-13;1-21-16(18-12-19-21)11-22-15-10-6-5-9-14(15)17(20-22)13-7-3-2-4-8-13;1-2-6-13(7-3-1)17-15-8-4-5-9-16(15)21(20-17)12-14-10-11-18-19-14;1-21-18-15(17-20-21)11-22-14-10-6-5-9-13(14)16(19-22)12-7-3-2-4-8-12/h2*2-11H,12H2,1H3;2-10,12H,11H2,1H3;1-10H,11-12H2;2-10H,11H2,1H3
InChIKeyRJRQBKOJPPXFNC-UHFFFAOYSA-N
XLogP16.14
TPSA244.87 Ų
H-Bond Donors
H-Bond Acceptors24
Rotatable Bonds15
Heavy Atoms109
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001432.68
LogP ≤ 516.14
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1024

Analyze 3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(3H-pyrazol-5-ylmethyl)indazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-Methyl-5-(1-methylimidazo[4,5-c]quinolin-2-yl)-1,2-oxazole;3-methyl-5-(3-methylimidazo[4,5-c]quinolin-2-yl)-1,2-oxazole
CID 70440670
3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(2H-triazol-4-ylmethyl)indazole
CID 158980504
3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(2H-triazol-4-ylmethyl)indazole
CID 160118657
2-[2-(benzylamino)benzimidazol-1-yl]-N-(3,4-dimethyl-1,2-oxazol-5-yl)acetamide;2-[2-(benzylamino)benzimidazol-1-yl]-N-(1-methylimidazol-4-yl)acetamide;2-[2-(benzylamino)benzimidazol-1-yl]-N-(1-methylpyrazol-3-yl)acetamide;2-[2-(benzylamino)benzimidazol-1-yl]-N-(2-methylpyrazol-3-yl)acetamide;2-[2-(benzylamino)benzimidazol-1-yl]-N-(1,2-oxazol-4-yl)acetamide
CID 161380156
[3-Methyl-4-([1,2,4]triazolo[4,3-a]pyrazin-8-yl)piperazin-1-yl]-[5-[[3-[4-[(2-phenylindol-1-yl)methyl]triazol-1-yl]piperidin-1-yl]methyl]-1,2-oxazol-3-yl]methanone
CID 166346757

Frequently Asked Questions

What is the IUPAC name of 3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(3H-pyrazol-5-ylmethyl)indazole?
The IUPAC name of 3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(3H-pyrazol-5-ylmethyl)indazole (CID 160645179) is 3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(3H-pyrazol-5-ylmethyl)indazole.
What is the SMILES notation for 3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(3H-pyrazol-5-ylmethyl)indazole?
The canonical SMILES for 3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(3H-pyrazol-5-ylmethyl)indazole is C1=C(Cn2nc(-c3ccccc3)c3ccccc32)N=NC1.Cc1cc(Cn2nc(-c3ccccc3)c3ccccc32)on1.Cn1cc(Cn2nc(-c3ccccc3)c3ccccc32)nn1.Cn1ncnc1Cn1nc(-c2ccccc2)c2ccccc21.Cn1nnc(Cn2nc(-c3ccccc3)c3ccccc32)n1.
What is the InChIKey of 3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(3H-pyrazol-5-ylmethyl)indazole?
The InChIKey is RJRQBKOJPPXFNC-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H15N3O.2C17H15N5.C17H14N4.C16H14N6/c1-13-11-15(22-20-13)12-21-17-10-6-5-9-16(17)18(19-21)14-7-3-2-4-8-14;1-21-11-14(18-20-21)12-22-16-10-6-5-9-15(16)17(19-22)13-7-3-2-4-8-13;1-21-16(18-12-19-21)11-22-15-10-6-5-9-14(15)17(20-22)13-7-3-2-4-8-13;1-2-6-13(7-3-1)17-15-8-4-5-9-16(15)21(20-17)12-14-10-11-18-19-14;1-21-18-15(17-20-21)11-22-14-10-6-5-9-13(14)16(19-22)12-7-3-2-4-8-12/h2*2-11H,12H2,1H3;2-10,12H,11H2,1H3;1-10H,11-12H2;2-10H,11H2,1H3.
What are the key properties of 3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(3H-pyrazol-5-ylmethyl)indazole?
3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(3H-pyrazol-5-ylmethyl)indazole has a molecular weight of 1432.68 g/mol, XLogP of 16.14, 15 rotatable bonds, 0 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 3-methyl-5-[(3-phenylindazol-1-yl)methyl]-1,2-oxazole;1-[(2-methyltetrazol-5-yl)methyl]-3-phenylindazole;1-[(1-methyltriazol-4-yl)methyl]-3-phenylindazole;1-[(2-methyl-1,2,4-triazol-3-yl)methyl]-3-phenylindazole;3-phenyl-1-(3H-pyrazol-5-ylmethyl)indazole is sourced from PubChem (CID 160645179), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).